default search action

combined dblp search
author search
venue search
publication search

ask others

Edward Briercheck

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

Conference and Workshop Papers

see FAQ

What is the meaning of the colors in the publication lists?

2023
[c1]
- view
  - electronic edition @ mlr.press (open access)
  - no references & citations available
- export record
  dblp key:
  - conf/ml4h/ShankarYKTSRNVB23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/ml4h/ShankarYKTSRNVB23
Vivek Shankar, Xiaoli Yang, Vrishab Krishna, Brent Tan, Oscar Silva, Rebecca Rojansky, Andrew Y. Ng, Fabiola Valvert, Edward Briercheck, David Weinstock, Yasodha Natkunam, Sebastian Fernandez-Pol, Pranav Rajpurkar:
LymphoML: An interpretable artificial intelligence-based method identifies morphologic features that correlate with lymphoma subtype. ML4H@NeurIPS 2023: 528-558

Informal and Other Publications

see FAQ

What is the meaning of the colors in the publication lists?

2023
[i1]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/corr/abs-2311-09574
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/corr/abs-2311-09574
Vivek Shankar, Xiaoli Yang, Vrishab Krishna, Brent Tan, Oscar Silva, Rebecca Rojansky, Andrew Y. Ng, Fabiola Valvert, Edward Briercheck, David Weinstock, Yasodha Natkunam, Sebastian Fernandez-Pol, Pranav Rajpurkar:
LymphoML: An interpretable artificial intelligence-based method identifies morphologic features that correlate with lymphoma subtype. CoRR abs/2311.09574 (2023)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.